January 10/Toronto/Marketwire -- BioExx Specialty Proteins Ltd. announced that Henry Linsert Jr. has been appointed to its board of directors to add additional, and direct, industry expertise and depth. The company has also accepted the retirement of Paul McClory from the board of directors, following more than 13 years involvement with the genesis and evolution of BioExx. The company further announces that it has selected KPMG LLP to serve as the company's independent auditor commencing with fiscal year 2011.

Appointment of New Director
Linsert, who is based near Washington, D.C., founded Columbia Biosciences Corporation in 2007 to develop new uses for algal fluorescent proteins and new purification technology to improve the performance of proteins and antibodies for therapeutics, diagnostics and biochemical reagents.